Expected Moves

Potential regulatory downgrade or OTC 'Caveat Emptor' designation evaluated from a 0.002 baseline due to chronic non-compliance.

Final realistic deadline from 0.001 for restructuring the $2.8M debt load into equity or executing an asset fire-sale.

Final operational update evaluated from 0.0005, determining if Brain Scientific retains any going-concern status.